Target intelligence / Profile preview

Induction of Anti-Tumor Immune Response Through Immunogenic Cell Death and Immune Infiltration (ICD-mediated Anti-Tumor Immunity)

Target
ICD-mediated Anti-Tumor Immunity
Molecular classification
Cell Death Pathway, Immune Response Pathway, Signal Transduction Pathway
01

Overview

The induction of anti-tumor immune responses through immunogenic cell death (ICD) and subsequent immune infiltration is a therapeutic strategy that leverages the body’s own immune system to recognize, attack, and remember tumor cells. This process involves regulated forms of cell death in cancer cells that actively stimulate both innate and adaptive immunity, leading to durable anti-tumor effects. Key components include the release of DAMPs, activation of dendritic cells, and T cell-mediated cytotoxicity.

Other names
Immunogenic Cell DeathICDDAMP-mediated immune responseAnti-tumor immunityTumor Microenvironment Modulation
02

Mechanism of action

Induction of immunogenic cell death (ICD) leading to release of DAMPs, activation of antigen-presenting cells (APCs), and subsequent T cell-mediated anti-tumor immunity.

03

Biological functions

Cell deathImmune responseAntigen presentationT cell activationNatural killer cell activationInflammation
04

Disease associations

CancerTumor microenvironmentImmunosuppression
05

Safety considerations

Off-target immune activationCytokine stormAutoimmunityTumor escape mechanismsDevelopment of resistance
06

Interacting drugs

Doxorubicin

5 more in the full profile.

07

Biomarkers

HMGB1 levelsCalreticulin exposureHSP70/90 expressionATP releaseType I interferon levelsCXCL10 levelsCD8+ T cell infiltrationNK cell activityTLR4 expression

Beyond the preview

Go deeper on Induction of Anti-Tumor Immune Response Through Immunogenic Cell Death and Immune Infiltration (ICD-mediated Anti-Tumor Immunity).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Induction of Anti-Tumor Immune Response Through Immunogenic Cell Death and Immune Infiltration (ICD-mediated Anti-Tumor Immunity).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call